Core Scientific (NASDAQ:CORZ) Stock Falls 8.1% – Time to Sell?

Shares of Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) dropped 8.1% during mid-day trading on Friday. The company traded as low as $12.39 and last traded at $12.2810. 1,709,369 shares changed hands during trading, a decline of 87% from the average session volume of 13,166,018 shares. The stock had previously closed at $13.36.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CORZ shares. Wall Street Zen raised Core Scientific from a “sell” rating to a “hold” rating in a research note on Saturday, November 7th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Core Scientific in a research note on Thursday, October 15th. Compass Point reaffirmed a “buy” rating and set a $36.00 target price on shares of Core Scientific in a research report on Wednesday, July 29th. BTIG Research restated a “buy” rating and set a $38.00 price objective on shares of Core Scientific in a research note on Thursday, October 15th. Finally, Zacks Research raised shares of Core Scientific from a “hold” rating to a “strong-buy” rating in a report on Tuesday, November 10th. Three equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $30.32.

Read Our Latest Stock Analysis on Core Scientific

Core Scientific Stock Down 15.2%

The firm has a market cap of $3.65 billion, a P/E ratio of -3.25 and a beta of 5.56. The firm’s 50-day simple moving average is $14.91 and its 200 day simple moving average is $19.23.

Core Scientific (NASDAQ:CORZ – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.52. The company had revenue of $232.87 million during the quarter, compared to analyst estimates of $196.54 million. Core Scientific had a negative return on equity of 70.05% and a negative net margin of 18.31%. As a group, analysts forecast that Core Scientific, Inc. will post 0.08 earnings per share for the current year.

Insider Activity at Core Scientific

In other Core Scientific news, Director Eric Weiss acquired 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 15th. The stock was bought at an average cost of $16.33 per share, with a total value of $97,980.00. Following the acquisition, the director owned 265,262 shares in the company, valued at approximately $4,331,728.46. This represents a 2.31% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $12.45, for a total transaction of $124,500.00. Following the completion of the transaction, the insider owned 1,113,286 shares of the company’s stock, valued at $13,860,410.70. This represents a 0.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 100,000 shares of company stock worth $1,553,400. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Core Scientific

Large investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in Core Scientific in the 2nd quarter worth about $719,649,000. Apollo Management Holdings L.P. purchased a new position in Core Scientific during the second quarter valued at approximately $115,671,000. Avala Global LP purchased a new position in Core Scientific during the second quarter valued at approximately $101,729,000. Bank of America Corp DE purchased a new position in Core Scientific during the second quarter valued at approximately $93,668,000. Finally, Squarepoint Ops LLC increased its holdings in Core Scientific by 64.1% during the 2nd quarter. Squarepoint Ops LLC now owns 2,686,177 shares of the company’s stock worth $68,739,000 after acquiring an additional 1,049,678 shares during the period.

About Core Scientific

(Get Free Report)

Core Scientific, Inc. is a U.S.-based digital infrastructure company that operates data centers and provides computing services. Its business includes mining bitcoin, which involves using specialized computers to help process transactions and secure the Bitcoin network, as well as hosting equipment for third-party mining customers. The company also provides data center infrastructure for high-performance computing workloads, including artificial intelligence applications. Its facilities and services are designed to support the power, cooling, and computing needs of these operations.

See Also

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.